Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-21T05:16:47.697Z Has data issue: false hasContentIssue false

Topodiagnosis of deafness: strategy for treatment of neurofibromatosis type 2

Published online by Cambridge University Press:  08 March 2006

Nikolaos Marangos
Affiliation:
The ENT Department, University of Freiburg, Germany
Matthias Stecker
Affiliation:
The ENT Department, University of Freiburg, Germany
Roland Laszig
Affiliation:
The ENT Department, University of Freiburg, Germany

Abstract

Neurofibromatosis type 2 (NF2) causes bilateral hearing loss due to tumour growth in the cerebellopontine angle. We report the results of promontory testing and transtympanic electrocochleography on subjects with deafness due to NF2 referred for an auditory brainstem implant. All 19 ears tested revealed loss of cochlear microphonics. Nine ears (mainly without previous treatment) revealed auditory perception during promontory stimulation, indicating cochlear deafness. One of these subjects has been successfully provided with a cochlear implant. The other 10 ears (mainly after previous surgery) revealed negative promontory stimulation, indicating additional retrocochlear deafness. These findings indicate that neurofibromas initially cause a cochlear deafness, so that a cochlear implant can be used if the auditory nerve can be preserved. This option has to be considered in rehabilitating patients with bilateral tumours due to NF2.

Type
Research Article
Copyright
Royal Society of Medicine Press Limited 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)